
Official website (http://www.biomarin.com/)
OverviewAI-generated
BioMarin Pharmaceutical is a global biotechnology company established in 1997. It operates as an active entity within the United States, specifically located in San Rafael. The organization is classified as a company and a funder.
The firm is incorporated in Delaware and functions as an operating entity in the pharmaceutical preparations industry. It is listed on the Nasdaq exchange under the ticker symbol BMRN. Its Central Index Key is 0001048477, and it follows the Standard Industrial Classification code 2834. The company’s fiscal year ends on December 31.
Synthesized by Vinony from 24 facts across 4 sources: Wikidata, Firecrawl, SEC EDGAR, ROR. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Company
BMRN- Industry
- Pharmaceutical Preparations
- Exchange
- Nasdaq
- State of incorporation
- DE
- Entity type
- operating
via SEC EDGAR
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1997
- Location
- San Rafael, United States
- Status
- Active
GRID grid.422932.c · ISNI 0000 0004 0507 5335
Official website

BioMarin Pharmaceutical | Global Biotechnology Company
BioMarin is a global biotechnology company that has developed medicines to treat conditions such as achondroplasia, severe hemophilia A, and several rare inherited and lysosomal storage diseases. Learn more.
biomarin.com →Link to the official site · 22,586 chars · not written by Vinony
Wikidata facts
- Instance of
- organization
- Part of
- Nasdaq-100
- Country
- United States
- Headquarters
- Novato
- Industry
- biotechnology
- Stock exchange
- Nasdaq
- Legal form
- Delaware corporation
- Official website
- www.biomarin.com
- Image
- BioMarin Headquarters.jpg
Show 1 more fact
- inception
- 1997-00-00
via Wikidata · CC0
~23 min read
Encyclopedic overview

From Unexpected Turns to Purposeful Impact ------------------------------------------
Excerpted from Wikipedia’s “BioMarin Pharmaceutical” article, available under the CC BY-SA 4.0 licence.